Bilcare

Bilcare Inventory

The Inventory of Bilcare (526853.BO) as of Nov 4, 2026 is 1.15 B INR. In the previous year, Inventory was 1.21 B INR — a change of -5.27% (lower).

Inventory

1.15 BINR

YoY

-5.27%

Last updated:

Inventory of Bilcare is 2026 1.15 B INR. Inventory of Bilcare was 2025 1.21 B INR. It decreases by -5.27% lower compared to the previous year.

The Bilcare Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
3.69 B INR
Jan 1, 2020
769.74 M INR
Jan 1, 2021
1.01 B INR
Jan 1, 2022
1.36 B INR
Jan 1, 2023
1.02 B INR
Jan 1, 2024
1.08 B INR
Jan 1, 2025
1.21 B INR
Jan 1, 2026
1.15 B INR
The Bilcare Inventory history
YEARInventoryYoY
1.15 BINR-5.27%
1.21 BINR+11.84%
1.08 BINR+6.14%
1.02 BINR-25.14%
1.36 BINR+35.21%
1.01 BINR+31.08%
769.74 MINR-79.16%
3.69 BINR-0.96%
3.73 BINR+12.70%
3.31 BINR-16.84%
3.98 BINR-3.39%
4.12 BINR-12.69%
4.72 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bilcare Stock analysis

What does Bilcare do? Bilcare Ltd. provides pharma packaging research solutions through specialty polymer films and aluminum foils for solid-dosage pharmaceutical products. The company offers global clinical services, R&D services, and anti-counterfeit technology (nCid) as part of its product portfolio. Bilcare handles domestic and global manufacturing of investigational medicinal products (IMPs) and placebos, including primary and secondary packaging with blinding techniques, interactive Web response systems (IWRS), and temperature-controlled storage. Its clients include pharmaceutical companies requiring packaging solutions, clinical trial support, and anti-counterfeit measures for their products. The firm operates manufacturing facilities in Pune, India, with global depots spread across approximately 30+ locations worldwide. Bilcare's services target pharmaceutical manufacturers seeking packaging innovation, clinical trial management, and secure product authentication. The company leverages its presence in India, Singapore, Germany, and the United States to serve international clients needing comprehensive packaging and clinical services. Bilcare's revenue streams come from the sale of specialty polymer films, aluminum foils, and anti-counterfeit technology (nCid). The company also generates income through manufacturing IMPs and placebos, packaging services, and clinical trial support including IWRS and temperature-controlled storage. Clients primarily consist of pharmaceutical firms requiring end-to-end packaging solutions and secure clinical trial execution. Bilcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bilcare stock

Inventory of Bilcare is 1.15 B INR in 2026.

Inventory of Bilcare changed from 1.21 B INR to 1.15 B INR, representing a -5.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Bilcare since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Bilcare historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Bilcare

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bilcare